It is considered a therapeutic target for cancer, metabolic and neurodegenerative diseases, such as Huntington’s disease and metabolic syndrome, and a variety of small molecule Sirt1 modulators have been developed [3,4,5]. Here, SIRT1 is linked to juvenile Huntington disease.